PGHL.BO Overview

Company Profile

Related stocks

AARTIPHARM.NS • India

AARTI PHARMALABS LIMITED

855.5 INR

801.58M USD 1Y +2.5%

STAR.NS • India

STRIDES PHARMA SCI LTD

1,085.3 INR

1.03B USD 1Y +37.4%

FDC.BO • India

FDC LTD.

330.1 INR

555.32M USD 1Y -27.9%

NATCOPHARM.NS • India

NATCO PHARMA LTD.

789.4 INR

1.5B USD 1Y -1.7%

ASTRAZEN.BO • India

ASTRAZENECA PHARMA INDIA LTD.

5,831.85 INR

1.51B USD 1Y -38.5%

ALIVUS.NS • India

ALIVUS LIFE SCIENCES LTD

1,326.3 INR

1.68B USD 1Y +45.4%

APLLTD.NS • India

ALEMBIC PHARMA LTD

800.95 INR

1.63B USD 1Y -14%

AKUMS.NS • India

AKUMS DRUGS AND PHARMA L

751.85 INR

1.19B USD 1Y +78.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

India

Region

Asia-Pacific

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

6/7 High

5Y Volatility

23.8% p.a.

Max Drawdown (5Y)

-31.5%

Sharpe Ratio (5Y)

-0.20

Beta Factor

0.18

Size Class

Large Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (23.8% p.a.).